Passer au contenu principal

SIL1 nucleotide exchange factor

La SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Conditions referring to this gene or chromosome

Other names

BAP

BiP-associated protein

MSS

SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)

SIL1 protein

SIL1_HUMAN

ULG5

Related patient information and medicines

Cancer de la gorge

Patient information leaflet

Cancer de la gorge

(The throat is usually sprayed with a local anaesthetic before use of a nasal endoscope, so that the procedure i... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Cancer de la bouche

Patient information leaflet

Cancer de la bouche

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Causes du cancer

Patient information leaflet

Causes du cancer

Certain facteurs de risque are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. How does cancer start. Different parts of the body such as organs, bones... Most cells have a centre called a nucleus. The nucleus in each cell contains thousands of genes which are made up from a chemical called DNA. The.

Leucémie lymphoblastique aiguë

Patient information leaflet

Leucémie lymphoblastique aiguë

Cell and chromosome analysis Detailed tests are done on. These find out the exact type of cell that is abnormal - for example, if the abnormal cells are immature B lymphocytes or immature T lymphocytes. The chromosomes within the cells are checked for certain changes. Chromosomes are the parts in the cell which contain DNA - the genetic makeup of.

Myélome

Patient information leaflet

Myélome

See Further Reading and References below. Dr Krishna Vakharia, 27th June 2023 Daratumumab avec bortezomib and dexamethasone for previously treated multiple myeloma NICE has recommended the above treatment regime for those people who have had one treatment already with lenalidomide or if the lenalidomide cannot be used again as a second line.

Occlusion de la veine rétinienne

Patient information leaflet

Occlusion de la veine rétinienne

Conditions which increase the risk of retinal vein occlusion include. High cholesterol/high lipid levels. Raised pressure in the eye (glaucoma). Diabetes. Smoking. Conditions which 'thicken' the blood. What are the symptoms of retinal vein occlusion. If you have retinal vein occlusion, you will usually notice a decrease in your vision in one eye..

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 Sept 2008 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.